Yayınlar & Eserler

Yayın Ağı
Makaleler 66
Tümü (66)
SCI-E, SSCI, AHCI (50)
SCI-E, SSCI, AHCI, ESCI (57)
ESCI (7)
Scopus (49)
TRDizin (12)
Diğer Yayınlar (3)

1. Crizanlizumab with or without hydroxyurea in patients with sickle cell disease (STAND): primary analyses from a placebo-controlled, randomised, double-blind, phase 3 trial

Abboud M. R., Cançado R. D., De Montalembert M., Smith W. R., Rimawi H., Voskaridou E., et al.
The Lancet Haematology , 2025 (SCI-Expanded) identifier identifier identifier

2. Multicentral Retrospective Analysis of Venetoclax-Based Treatments in AML and MDS: A Real-World Study by the Turkish Hematology Network Group

Acar I. H., Aslaner Ak M., AKYOL G., Kars T. U., Ipek Y., Uysal A., et al.
Medicina (Lithuania) , cilt.60, sa.10, 2024 (SCI-Expanded) identifier identifier

3. The effect of obesity on oxidative stress parameters in pregnant women

Kocamaz D., Atlı Demiray G., Menziletoğlu Yıldız Ş. S., Arlıer S., Güvenç B.
Interdisciplinary Medical Journal , cilt.14, sa.48, ss.164-168, 2023 (Hakemli Dergi) Creative Commons License Sürdürülebilir Kalkınma

4. Efficacy of Bendamustine, Pomalidomide, and Dexamethasone (BPD) Regimen in Relapsed/Refractory Extramedullary Myeloma: A Retrospective Single-Centre Study, Real-Life Experience

Açar H. İ., Güvenç B.
HEMATOLOGY REPORTS , cilt.15, sa.3, ss.465-473, 2023 (ESCI) Creative Commons License

5. Oküler Graft Versus Host Hastalığında Prognozu Etkileyen Faktörler

Gul Olke K., ERDEM E., HARBİYELİ İ. İ., Dinçyürek H. D., GÜVENÇ B., KARAGÜN B., et al.
MN Oftalmoloji , cilt.30, sa.2, ss.112-118, 2023 (Hakemli Dergi) identifier

6. Unmet clinical needs and challenges in the management of acute leukemia in Turkey: a modified Delphi study.

Arat M., Alacacioglu I., Bolaman A. Z., Buyukasik Y., Cagirgan S., Güvenc B., et al.
Future oncology (London, England) , 2023 (SCI-Expanded) identifier

7. The Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients With Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Multicenter Real-Life Data.

Aslaner Ak M., Gedük A., Acar İ. H., Polat M. G., Sunu C., Bolaman A. Z., et al.
Turkish journal of haematology : official journal of Turkish Society of Haematology , cilt.40, ss.92-100, 2023 (SCI-Expanded) Creative Commons License identifier identifier

8. Clinical Characteristics and Outcomes of Cancer Cases Among Syrian Refugees From Southern Turkey.

Kutluk T., Sahin B., Kirazli M., Ahmed F., Aydin S., Yesil Çinkir H., et al.
JAMA network open , cilt.6, sa.5, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

9. The Use of Gemtuzumab Ozogamicin as Salvage Therapy in Patients with Acute Myeloid Leukemia: A Monocentric Real-World Experience.

Açar İ. H., Guvenc B.
Medicina (Kaunas, Lithuania) , cilt.59, sa.3, 2023 (SCI-Expanded) Creative Commons License identifier identifier identifier

10. Impact of COVID-19 on Outcomes of Patients with Hematologic Malignancies: A Multicenter, Retrospective Study

Acar I. H., Guner S. I., Aslaner Ak M., Gocer M., ÖZTÜRK E., Atalay F., et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , cilt.14, 2022 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

11. Reference Intervals of Hematological Parameters in a Large Sample of Turkish Population from the Cukurova Region of Turkey

KOÇ A. F., MENZİLETOĞLU YILDIZ Ş. S., GÜVENÇ B., KOKANGÜL A., İŞCAN D.
ERCIYES MEDICAL JOURNAL , cilt.44, sa.5, ss.473-480, 2022 (ESCI) identifier

12. Reference Intervals of Hematological Parameters in a Large Sample of the Turkish Population in the Cukurova District of Turkiye

Koc G. G., Kokangul A., Iscan D., Yildiz S. M., Karaboga G., Guvenc B.
ERCIYES MEDICAL JOURNAL , cilt.44, sa.5, ss.473-480, 2022 (ESCI) identifier identifier

13. Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first-line systemic treatment or best supportive care: A multicenter international study

Ito T., Sanford D., Tomuleasa C., Hsiao H., Olivera L. J. E., Enjeti A. K., et al.
EUROPEAN JOURNAL OF HAEMATOLOGY , cilt.109, sa.1, ss.58-68, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

14. The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.

Saydam G., Ali R., Demir A. M., Eskazan A. E., Guvenc B., Haznedaroglu I. C., et al.
International journal of hematologic oncology , cilt.11, sa.1, 2022 (Hakemli Dergi) Creative Commons License identifier

15. The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study.

Ak M. A., Sahip B., Geduk A., Ucar M. A., Kale H., Hacibekiroglu T., et al.
Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion , cilt.38, sa.2, ss.299-308, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

16. Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy*

Miyamoto T., Sanford D., Tomuleasa C., Hsiao H., Enciso Olivera L. J., Kumar Enjeti A., et al.
LEUKEMIA & LYMPHOMA , cilt.63, sa.4, ss.928-938, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

17. Real world results of venetoclax combined with hypomethylating agents in relapsed/refractory AML.

Ucar M. A., Ozet G., Koyuncu M. B., Sonmez M., Akidan O., Ayli M., et al.
European review for medical and pharmacological sciences , cilt.25, sa.21, ss.6557-6565, 2021 (SCI-Expanded) identifier identifier identifier

18. Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey.

Soyer N., Ali R., Turgut M., Haznedaroğlu İ. C., Yılmaz F., Aydoğdu İ., et al.
Turkish journal of medical sciences , cilt.51, sa.3, ss.1033-1042, 2021 (SCI-Expanded) identifier identifier identifier identifier

19. Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis.

Karadag F. K., Yenerel M. N., Yılmaz M., Uskudar H., Ozkocaman V., Tuglular T. F., et al.
American journal of blood research , cilt.11, sa.3, ss.279-285, 2021 (ESCI) identifier

20. Evolution of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in turkey: a multicenter retrospective analysis

Karadag F. K., Yenerel M. N., Yilmaz M., Uskudar H., Ozkocaman V., Tuglular T. F., et al.
AMERICAN JOURNAL OF BLOOD RESEARCH , cilt.11, sa.3, ss.279-285, 2021 (ESCI) identifier

21. Kronik Miyeloid Lösemide Mutasyonların Araştırılması ve Klinikle Olan İlişkilerinin İncelenmesi

AYTAN P., GEREKLİOĞLU Ç., GÜVENÇ B.
Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi , cilt.11, sa.4, ss.202-223, 2020 (Hakemli Dergi)

22. Study for the Diagnostic Screening of Paroxysmal Nocturnal Hemoglobinuria in Older Patients with Unexplained Anemia and/or Cytopenia

Ozdemir Z. N., İLHAN O., Ozet G., Falay M., Yenerel M., Tuglular T., et al.
CLINICAL LABORATORY , cilt.66, sa.9, ss.1709-1715, 2020 (SCI-Expanded) identifier identifier identifier

23. Study for the diagnostic screening of paroxsymal nocturnal hemoglobinuria in Turkey: Prospective multicentric evaluation of suspected patients.

Ilhan O., Ozdemir Z. N., Ozet G., Falay M., Yenerel M., Tuglular T., et al.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis , cilt.58, sa.5, ss.659-662, 2019 (SCI-Expanded) identifier identifier identifier

24. External quality assessment reports: six years experiences as a participating blood center from Turkey

KOCAMAZ D., Yildiz S. M., Dengiz H., Karaboga G., GÜVENÇ B.
CUKUROVA MEDICAL JOURNAL , cilt.44, ss.24-27, 2019 (ESCI) identifier

25. Association between MTHFR C677/APOB G10708B Polymorphisms and Excess Body Weight in Blood Donors

Yildiz S. M., KOCAMAZ D., GÜVENÇ B.
INTERNATIONAL JOURNAL OF HUMAN GENETICS , cilt.18, sa.4, ss.253-258, 2018 (SCI-Expanded) Creative Commons License identifier

26. Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up

SAYDAM G., HAZNEDAROĞLU İ. C., KAYNAR L., Yavuz A., Ali R., GÜVENÇ B., et al.
HEMATOLOGY , cilt.23, sa.10, ss.771-777, 2018 (SCI-Expanded) Creative Commons License identifier identifier identifier

27. frequency of venous thrombosis related dna polymorphism in healthy turkish population

MENZİLETOĞLU YILDIZ Ş. S., Kocamaz D., GOZET Y., GÜVENÇ B.
FRESENIUS ENVIRONMENTAL BULLETIN , cilt.27, ss.4797-4801, 2018 (SCI-Expanded) Creative Commons License

28. Paroxysmal nocturnal hemoglobinuria case presenting as cerebral venous sinus thrombosis

SÜMBÜL H. E., BÜYÜKŞİMŞEK M., Saraçoğlu S. M., GÜVENÇ B.
Journal of Surgery and Medicine , cilt.2, sa.2, ss.190-192, 2018 (Hakemli Dergi)

29. FREQUENCY OF VENOUS THROMBOSIS RELATED DNA POLYMORPHISMS IN A HEALTHY TURKISH POPULATION

MENZILETOGLU-YILDIZ S., KOCAMAZ D., Nyrahabimana F., GOZET Y., GÜVENÇ B.
FRESENIUS ENVIRONMENTAL BULLETIN , cilt.27, sa.7, ss.4797-4801, 2018 (SCI-Expanded) identifier

30. THE MODELLED EFFECTIVENESS OF RUXOLITINIB ON SURVIVAL IN POLYCYTHEMIA PATIENTS WITH HYDROXYUREA RESISTANCE/INTOLERANCE IN TURKEY

Buyukasik Y., Haznedaroglu I., Ozet G., Ar C., Ozcan M. A., Guvenc B., et al.
VALUE IN HEALTH , cilt.20, sa.9, 2017 (SCI-Expanded) identifier

31. EPIDEMIOLOGICAL ESTIMATES AND TREATMENT PRACTICE PATTERN IN POLYCYTHEMIA VERA PATIENTS IN TURKEY: RESULTS BASED ON AN EXPERT PANEL

Buyukasik Y., Haznedaroglu I., Ozet G., Ar C., Ozcan M. A., Guvenc B., et al.
VALUE IN HEALTH , cilt.20, sa.9, 2017 (SCI-Expanded) identifier

32. Major Histocompatibility Complex Class I-related Chain A and B Gene Expression in Sepsis Patient

Yildiz S. M., ATLI G., GÜLEÇ E., GÜVENÇ B., ÖZCENGİZ D.
INTERNATIONAL JOURNAL OF HUMAN GENETICS , cilt.17, sa.1, ss.26-30, 2017 (SCI-Expanded) identifier

33. Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase

SAYDAM G., HAZNEDAROĞLU İ. C., KAYNAR L., Yavuz A., Ali R., GÜVENÇ B., et al.
EXPERT OPINION ON PHARMACOTHERAPY , cilt.17, sa.14, ss.1851-1858, 2016 (SCI-Expanded) identifier identifier identifier identifier

34. Plasmapheresis in the Treatment of Acute Liver Failure: A Case Report and a Review of the Literature

Ulu A., KURAN S., KURTARAN B., İNAL A. S., KÖMÜR S., TEKINTURHAN F., et al.
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , cilt.21, sa.3, ss.98-101, 2015 (ESCI) Sürdürülebilir Kalkınma identifier

35. Hepatitis B, Hepatitis C, Human immunodeficiency virus and syphilis frequency among blood donors: A single center study.

Yildiz S. M., Candevir A., KİBAR F., Karaboga G., Turhan F. T., Kis C., et al.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis , cilt.53, sa.3, ss.308-14, 2015 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

36. Nilotinib Results in Improved Rates of Molecular Response in Turkish Newly Diagnosed CML-CP Patients: A 24-Month Update

SAYDAM G., HAZNEDAROĞLU İ. C., KAYNAR L., Yavuz A., Ali R., GÜVENÇ B., et al.
BLOOD , cilt.124, sa.21, 2014 (SCI-Expanded) identifier

37. Radioisotope synovectomy in severe hemophiliac patients with chronic synovitis in target joints: Six years of experience at Cukurova University by the medical faculty hemophilia team

Antmen B., Sasmaz I., Özkan C., Kozanoglu E., Karagun B., Güvenç B., et al.
HAEMOPHILIA , cilt.20, ss.68, 2014 (SCI-Expanded) identifier

38. Circumcision and complications in adolescent and adult patients with hemophilia in southern Turkey: Cukurova experience

Antmen B., Sasmaz I., GÜVENÇ B., LEBLEBİSATAN G., Karagun B., KILINÇ Y., et al.
HAEMOPHILIA , cilt.20, ss.80, 2014 (SCI-Expanded) identifier

39. Donor Granulocyte Transfusions in Febrile Neutropenic Pediatric Oncology Patients

SEZGİN G., Acipayam C., Turhan F. T., Ozkan A., KÜPELİ S., BAYRAM İ., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.2, ss.75-81, 2014 (SCI-Expanded) identifier identifier

40. The Comparison of Standard and Salvage Chemotherapy Regimens Regarding to CD34(+) Peripheric Stem Cell Harvesting Success

Balcik O. S., Aksoy C., Akdeniz D., Akkaya C., GÜVENÇ B., Dincer S.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.23, sa.3, ss.184-192, 2013 (SCI-Expanded) identifier identifier

41. beta-Globin chain abnormalities with coexisting alpha-thalassemia mutations

GÜVENÇ B., Canataroglu A., Unsal C., Yildiz Ş. S., Turhan F. T., Bozdogan S. T., et al.
ARCHIVES OF MEDICAL SCIENCE , cilt.8, sa.4, ss.644-649, 2012 (SCI-Expanded) Creative Commons License identifier identifier identifier

42. beta-Thalassemia mutations and hemoglobinopathies in Adana, Turkey: results from a single center study

GÜVENÇ B., Canataroglu A., Unsal C., Yildiz S. M., Turhan F. T., Bozdogan S. T., et al.
ARCHIVES OF MEDICAL SCIENCE , cilt.8, sa.3, ss.411-414, 2012 (SCI-Expanded) Creative Commons License identifier identifier identifier

43. Loss of CD20 antigen expression after rituximab therapy of CD20 positive B cell lymphoma (diffuse large B cell extranodal marginal zone lymphoma combination): A case report and review of the literature

DUMAN B. B., ŞAHİN B., ERGIN M., GUVENC B.
MEDICAL ONCOLOGY , cilt.29, sa.2, ss.1223-1226, 2012 (SCI-Expanded) identifier identifier identifier

44. Lymphoma of the breast in a male patient

DUMAN B. B., ŞAHİN B., GUVENC B., ERGIN M.
MEDICAL ONCOLOGY , cilt.28, 2011 (SCI-Expanded) identifier identifier identifier

45. Treatment of acute carbon-monoxide poisoning with therapeutic erythrocytapheresis: Clinical effects and results in 17 victims

Celikdemir A., GÖKEL Y., GÜVENÇ B., Tekinturan F.
TRANSFUSION AND APHERESIS SCIENCE , cilt.43, sa.3, ss.327-329, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

46. Molecular Characterization of alpha-Thalassemia in Adana, Turkey: A Single Center Study

GÜVENÇ B., Yildiz S. M., Tekinturhan F., Dincer S., Akyuzluer I., Okten S., et al.
ACTA HAEMATOLOGICA , cilt.123, sa.4, ss.197-200, 2010 (SCI-Expanded) identifier identifier identifier

47. Severe acetaminophen poisoning treated with a fractionated plasma separation and absorption system: A case report

SEBE A., Satar S., ALPAY N., Murt M., GÜVENÇ B.
HUMAN & EXPERIMENTAL TOXICOLOGY , cilt.28, sa.11, ss.729-732, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

48. A Case Report of the Cascade Filtration System: A Safe and Effective Method for Low-density Lipoprotein Apheresis During Pregnancy

Ertorer M. E., GÜVENÇ B., Haydardedeoglu B., Tekinturhan F.
THERAPEUTIC APHERESIS AND DIALYSIS , cilt.12, sa.5, ss.396-400, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

49. The effect of antiepileptic drugs on vitamin B12 metabolism

ASLAN K., BOZDEMİR H., Unsal C., Guevenc B.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY , cilt.30, sa.1, ss.26-35, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

50. Renal vascular resistance in sickle cell painful crisis

Guvenc B., Aikimbaev K., Unsal C., Akgul E., Gurkan E., Binokay F., et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY , cilt.82, sa.2, ss.127-131, 2005 (SCI-Expanded) identifier identifier identifier

51. In vitro effect of trimetazine on K-Cl cotransport and superoxide dismutase activity in Hemoglobin SS erythrocytes

Guvenc B., Unsal C., Menziletoglu S., Gurkan E., Nevruz O., Guvenc H.
PERIODICUM BIOLOGORUM , cilt.107, sa.2, ss.231-234, 2005 (SCI-Expanded) identifier

52. Sickle cell anemia patient with sarcoidosis-associated inguinal lymph node and lung infiltration.

Güvenç B., Unsal C., Hanta I., Unsal A., Güvenç H.
Journal of the National Medical Association , cilt.97, sa.6, ss.820-2, 2005 (SCI-Expanded) identifier identifier

53. Thrombotic thrombocytopenic purpura in southern Turkey: a single-center experience of 29 cases

Gurkan E., Baslamisli F., Guvenc B., Kilic N., Unsal C., Karakoc E.
CLINICAL AND LABORATORY HAEMATOLOGY , cilt.27, sa.2, ss.121-125, 2005 (SCI-Expanded) identifier identifier identifier

54. In vitro effect of trimetazine on K Cl cotransport and superoxidedismutase activity in Hemoglobin SS erythrocytes

GÜVENÇ B., Menziletoglu S.
PERIODICUM BIOLOGORUM , cilt.107, sa.2, ss.231-234, 2005 (SCI-Expanded) Creative Commons License

55. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report.

Guvenc B., Unsal C., Gurkan E., Canataroglu A., Saritas B., Evran M.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis , cilt.31, sa.1, ss.17-20, 2004 (SCI-Expanded) identifier identifier identifier

56. Anti-D and Intravenous Immunoglobulin Treatments in Chronic Idiopathic Thrombocytopenic Purpura.

Ünsal Ç., Gürkan E., Güvenç B., Başlamışlı F., Canataroğlu A.
Turkish journal of haematology : official journal of Turkish Society of Haematology , cilt.21, sa.1, ss.27-32, 2004 (Scopus) identifier identifier

57. Plasmapheresis in the treatment of hyperthyroidism associated with agranulocytosis: A case report

Guvenc B., Unsal C., Gurkan E., Dincer S.
JOURNAL OF CLINICAL APHERESIS , cilt.19, sa.3, ss.148-150, 2004 (SCI-Expanded) identifier identifier identifier

58. Immune thrombocytopenic purpura associated with Brucella and Toxoplasma infections

Gurkan E., Baslamisli F., Guvenc B., Bozkurt B., Unsal C.
AMERICAN JOURNAL OF HEMATOLOGY , cilt.74, sa.1, ss.52-54, 2003 (SCI-Expanded) identifier identifier identifier

59. Value of duplex and color Doppler ultrasonography in the evaluation of orbital vascular flow and resistance in sickle cell disease

Aikimbaev K., Guvenc B., Canataroglu A., Canataroglu H., Baslamisli F., Oguz M.
AMERICAN JOURNAL OF HEMATOLOGY , cilt.67, sa.3, ss.163-167, 2001 (SCI-Expanded) identifier identifier identifier

60. Multiple myeloma with skin involvement

Guvenc B., Canataroglu A., Gumurdulu Y., Gumudulu D., Paydas S.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , cilt.15, sa.4, ss.328-329, 2001 (SCI-Expanded) identifier identifier identifier

61. Neuroacanthocytosis presenting with epileptic seizures

DEMİRKIRAN D. M., BOZDEMİR H., GÜVENÇ B., SARICA Y.
Annals of Medical Sciences , cilt.10, ss.82-84, 2001 (Hakemli Dergi)

62. Stimulation of human erythrocyte K-Cl cotransport and protein phosphatase type 2A by n-ethylmaleimide: Role of intracellular Mg++

Bize I., Guvenc B., Buchbinder G., Brugnara C.
JOURNAL OF MEMBRANE BIOLOGY , cilt.177, sa.2, ss.159-168, 2000 (SCI-Expanded) identifier identifier identifier

63. The Levels of Sera Malondialdehyde, Erythrocyte Membrane Na+-K+/Mg++ and Ca++/Mg++ Adenosine 5' Triphosphatase in Patients with Sickle Cell Anemia.

Tamer L., Polat G., Yücebilgiç G., Güvenç B., Başlamışlı F.
Turkish journal of haematology : official journal of Turkish Society of Haematology , cilt.17, sa.1, ss.23-6, 2000 (Scopus) identifier identifier

64. Serine/threonine protein phosphatases and regulation of K-Cl cotransport in human erythrocytes.

Bize I., Güvenç B., Robb A., Buchbinder G., Brugnara C.
The American journal of physiology , cilt.277, sa.5, 1999 (Scopus) identifier identifier

65. Spectral pulsed Doppler sonography of renal vascular resistance in sickle cell disease: Clinical implications

AIKIMBAEV K., OGUZ M., Guvenc B., BASLAMISLI F., KOCAK R.
BRITISH JOURNAL OF RADIOLOGY , cilt.69, sa.828, ss.1125-1129, 1996 (SCI-Expanded) identifier identifier identifier

66. Bencyclane as an anti-sickling agent

Kocak R., Baslamisli F., Guvenc B., Tamer L., Aikimbaev K., Isbir T.
BRITISH JOURNAL OF HAEMATOLOGY , cilt.92, sa.2, ss.329-331, 1996 (SCI-Expanded) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 88

1. Marginal Zone Lymphoma in the Landscape of Autoimmune Complexity: A Case Report With Sjögren Syndrome and Hashimoto Thyroiditis

Tozluklu N. N., ERGİN M., GÜVENÇ B., AÇIKALIN A.
Proceedings of the Society of Hematologic Oncology 2024 Annual Meeting, Texas, Amerika Birleşik Devletleri, 04 Eylül 2024, cilt.24, ss.424, (Tam Metin Bildiri) identifier

2. The Intersection of Thalassemia Minor and Chronic Myeloproliferative Disorders: Clinical and Laboratory Implications

Emirüyükaşık E., GÜVENÇ B.
Proceedings of the Society of Hematologic Oncology 2024 Annual Meeting, Texas, Amerika Birleşik Devletleri, 04 Eylül 2024, cilt.21, ss.423-424, (Tam Metin Bildiri) identifier

3. Neoadjuvant chemoimmunotherapy for a patient with micro-stallete instabile gastric cancer resulted a pathological complete response

ŞAHİN B., GÜVENÇ B.
X Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 28 - 30 Nisan 2024, cilt.46, ss.11-12, (Tam Metin Bildiri)

4. Essential Thrombocythemia Complicated by Addison's Disease: A Case of Overlapping Endocrine and Hematological Disorders

ŞENER M., NISANOGLU K., MUMCU C., DUMAN B. E., ISCI B. N., BAL E., et al.
X Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 28 Nisan 2024, cilt.46, ss.10, (Tam Metin Bildiri)

5. Two Follicular Dendritic Cell Sarcoma (FDCS) patients treated with Chemoimmunotherapy

ŞAHİN B., GÜVENÇ B.
X Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 28 - 30 Nisan 2024, cilt.46, ss.11, (Tam Metin Bildiri)

6. A Rare Intersection: Case Study on Sickle-Cell Thalassemia and Lymphoma

GÜVENÇ B., ŞENER M., MUMCU C., DUMAN B. E., ISCI B. N., BAL E., et al.
X Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 28 Nisan 2024, cilt.46, ss.10, (Tam Metin Bildiri)

7. A Case of Multiple Myeloma with Atypical Cutaneous Presentation Treated by Daratumumab + CYBORG

DUMAN B. E., MUMCU C., ISCI B. N., BAL E., ŞENER M., YANAR H., et al.
X Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 28 Nisan 2024, cilt.46, ss.9-10, (Tam Metin Bildiri)

8. Peripheral T-cell Lymphoma with Jaundice: Insights from a Complex Case

MUMCU C., DUMAN B. E., ISCI B. N., BAL E., KABALCI KADIOGLU I., SAT B., et al.
X Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 28 Nisan 2024, cilt.46, ss.11, (Tam Metin Bildiri)

9. From Diagnosis to Recovery: Addressing Rare Malaria with Travel History Using Standard and Apheresis Therapies

ŞENER M., YALDIZ H. N., MUMCU C., DUMAN B. E., ISCI B. N., BAL E., et al.
X Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 28 - 30 Nisan 2024, cilt.46, ss.27, (Tam Metin Bildiri)

10. Challenging the Presentation Paradigm in DLBCL: A Case Study of Extraordinary Disease Distribution

DUMAN B. E., MUMCU C., COZELI M., ISCI B. N., BAL E., ŞENER M., et al.
X Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 28 Nisan 2024, cilt.46, ss.26, (Tam Metin Bildiri)

11. Efficacy, Safety, and Biomarker Analysis of 5 Mg and 7.5 Mg Doses of Crizanlizumab in Patients with Sickle Cell Disease: Primary Analyses from the Phase III STAND Study

Abboud M. R., Cançado R. D., De Montalembert M., Smith W. R., Rimawi H., Voskaridou E., et al.
65th American Society of Hematology (ASH) Annual Meeting and Exposition, San Diego, Amerika Birleşik Devletleri, 9 - 12 Aralık 2023, cilt.142, ss.272, (Tam Metin Bildiri)

12. Kritik Hasta Çocuklarda Terapötik Plazma Değişimi: Üçüncü Basamak Pediatrik Yoğun Bakım Ünitesinde 18 Yıllık Deneyim

TELEFON H. A., EKİNCİ F., YILDIZDAŞ R. D., ÖZGÜR HOROZ Ö., YÖNTEM A., AÇAR İ. H., et al.
19.Ulusal Çocuk Acil Tıp ve Yoğun Bakım Kongresi, Antalya, Türkiye, 22 - 25 Kasım 2023, (Özet Bildiri)

13. UNRAVELING BLOOD DONOR DEFERRAL TRENDS: A REAL-WORLD SINGLE-CENTER STUDY

AÇAR İ. H., MENZİLETOĞLU YILDIZ Ş. S., GÜVENÇ B.
XIV Eurasian Hematology Oncology Congress, 11 - 14 Ekim 2023, cilt.45, ss.42, (Tam Metin Bildiri)

14. A RARE INTERSECTION: COEXISTENCE OF BREAST CANCER AND SICKLE CELL DISEASE IN A 40- YEAR-OLD FEMALE - A CASE REPORT

GÜVENÇ B., Yürekli İ., ŞAHİN B.
XIV Eurasian Hematology Oncology Congress, 11 Ekim 2023, cilt.45, ss.47, (Tam Metin Bildiri)

15. RICHTER SYNDROME TRANSFORMATION UNDER VENETOCLAX TREATMENT: A CASE REPORT OF A 51-YEAR-OLD FEMALE WITH CLL

AÇAR İ. H., GÜVENÇ B.
XIV Eurasian Hematology Oncology Congress, Türkiye, 11 - 14 Ekim 2023, cilt.45, ss.0-3, (Tam Metin Bildiri)

16. IBRUTIINIIB-OBI INUTUZUMAB COMBIINATIION THERAPY IN THE TREATMENT OF RELAPSED NODAL MARGIINAL ZONE LYMPHOMA: A CASE STUDY

GÜL AÇAR N., AÇAR İ. H., GÜVENÇ B.
XIV Eurasian Hematology Oncology Congress, 11 - 14 Ekim 2023, cilt.45, ss.14, (Tam Metin Bildiri)

17. THE CLINICAL EFFICACY OF EPOETIN ALFA AND DARBEPOETIN ALFA IN PATIENTS WITH LOW-RISK OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROME: RETROSPECTIVE MULTI-CENTER REAL-LIFE STUDY

ASLANER AK M., SAHİP YESİRALİOĞLU B., GEDÜK A., UÇAR M. A., HACIBEKİROĞLU T., POLAT M. G., et al.
XIV Eurasian Hematology Oncology Congress, 11 - 14 Ekim 2023, cilt.45, ss.39, (Tam Metin Bildiri)

18. UNUSUAL PRESENTATION OF RHABDOMYOSARCOMA WITH BONE MARROW INVOLVEMENT AND CERVIICAL MASS: A 17-YEAR-OLD FEMALE CASE REPORT

GÜL AÇAR N., AÇAR İ. H., ŞAHİN B., GÜVENÇ B.
XIV Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 11 - 14 Ekim 2023, cilt.45, ss.20, (Tam Metin Bildiri)

19. GLOBAL RESEARCH PATTERNS ON BLOOD DONOR DEFERRAL: AN ANALYSIS OF THEMES, TRENDS, AND INFLUENCE

GÜVENÇ B., AÇAR İ. H., MENZİLETOĞLU YILDIZ Ş. S.
XIV Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 11 - 14 Ekim 2023, cilt.45, ss.20, (Tam Metin Bildiri)

20. URETERAL AMYLOIIDOSIIS: A CASE REPORT OF SUCCESSFUL MANAGEMENT WIITH SURGERY, RADIIATIION, AND CHEMOTHERAPY

AÇAR İ. H., GÜL AÇAR N., GÜVENÇ B.
XIV Eurasian Hematology Oncology Congress, 11 - 14 Ekim 2023, cilt.45, ss.15, (Tam Metin Bildiri)

21. İki Olgu Nedeniyle Niemann-Pick tip B'de Splenik rüptür; Fatal bir Komplikasyon ve Tanı Aracı

KÖŞECİ B., kara e., KAPLAN İ., BURGAÇ E., BULUT F. D., KOR D., et al.
VIII. Uluslararası Katılımlı LizozomaI Hastalıklar Kongresi, 3 - 07 Mayıs 2023, (Özet Bildiri)

22. Gebelikte Tanı Konulan Aml Hastasının Yönetimi

ŞENER M., GÜVENÇ B.
Hematoloji Uzmanlık Derneği 16.Ulusal Kongresi, Mersin, Türkiye, 18 - 20 Kasım 2022, ss.69, (Tam Metin Bildiri)

23. Assesment of Patient'S Perspective on Treatment Free Remission in CML: A Turkish Multicenter Cohort

Mutlu Y. g., Guvenc B., Serin I., Aydin B. B., Alacacioglu I., Guven S., et al.
cilt.140, ss.11490, (Özet Bildiri) identifier

24. AMİLOİDOZ VE VWF EKSİKLİĞİ İLE GİDEN IGG TİPİ LENFOPLAZMASİTİK LENFOMA OLGUSU

ŞENER M., GÜVENÇ B.
10.EGE HEMATOLOJİ ONKOLOJİ KONGRESİ, İzmir, Türkiye, 17 - 19 Mart 2022, (Tam Metin Bildiri)

25. PATTERNS OF HEALTHCARE RESOURCE UTILIZATION (HRU) IN UNFIT PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) RECEIVING FIRST-LINE SYSTEMIC TREATMENT OR BEST SUPPORTIVE CARE (BSC): A MULTICENTER INTERNATIONAL STUDY (CURRENT)

Ito T., Sanford D., Tomuleasa C., Hsiao H. H., Enciso Olivera L. J., Enjeti A. K., et al.
cilt.24, (Özet Bildiri) identifier

26. Disturbance of CALR mutation profile in MPNs by NGS and Real-Time PCR

Rencuzogullari C., Bozdogan S. T., GÜVENÇ B., BİŞGİN A.
AACR Annual Meeting, ELECTR NETWORK, 22 - 24 Haziran 2020, cilt.80, (Özet Bildiri) identifier

27. Crizanlizumab Versus Placebo, with or without Hydroxyurea/Hydroxycarbamide, in Adolescent and Adult Patients with Sickle Cell Disease and Vaso-Occlusive Crises: A Randomized, Double-Blind, Phase III Study (STAND)

Abboud M. R., Howard J., Cancado R., Smith W. R., Guvenc B., Espurz N., et al.
cilt.134, (Özet Bildiri) identifier

28. Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey

Karadag F. K., Yenerel M. N., Mehmet Y., Teke H. U., Ozkocaman V., Tuglular T., et al.
cilt.134, (Özet Bildiri) identifier

29. Erdheim-Chester hastalığı adrenal tutulumu: olgu sunumu

İZOL V., DEĞER M., ŞÜKÜR İ. H., ERDOĞAN Ş., GÜVENÇ B., TANSUĞ M. Z.
14. Üroonkoloji Kongresi, Türkiye, 6 - 10 Kasım 2019, (Özet Bildiri)

30. Case report: concomitant myelodysplasia in a patient with syphilis

Dincyurek H. D., Cor S., Gozcu N., Guvenc B.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri) identifier

31. Single center experience: long-term treatment results in thrombotic thrombocytopenic purpura

Gul K., Guvenc B., Tekinturhan F., Dincyurek H. D., Cor S.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri) identifier

32. First use of plasmapheresis in the treatment of T cell engaging therapies related adverse effects

Dincyurek H. D., Mutlu Y. G., Sahin B., Ertop S., Guvenc B.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri) identifier

33. Cukurova University experience of lysosomal diseases in adulthood: Report of 57 patients

MUNGAN N., BULUT F. D., SEKER-YILMAZ B., KILAVUZ S., KOR D., Koc F., et al.
We're Organizing Research for Lysosomal Diseases (WORLD) Symposium, California, Amerika Birleşik Devletleri, 5 - 09 Şubat 2018, cilt.123, (Özet Bildiri) identifier

34. THE EFFECTS OF OBESITY AND AGE ON TOTAL ANTIOXIDANT/OXIDANT STATUS IN HEALTY ADULTS

MENZİLETOĞLU YILDIZ Ş. S., Kocamaz D., ÇOĞUN H. Y., GÜVENÇ B.
INTERNATIONAL CONGRESS OF HEALTH AND ENVIRONMENT, 23 - 25 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

35. ASSESMENT OF THE MTHFR C677T AND APOB G10708A GENE POLYMORPHISMS RELATED TO CARDIOVASCULAR DISEASES IN HEALTHY BLOOD DONORS

MENZİLETOĞLU YILDIZ Ş. S., GÜVENÇ B., kocamaz D.
INTERNATIONAL CONGRESS OF HEALTH AND ENVIRONMENT, 23 - 25 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

36. KRONİK MYELOPROLİFERATİF NEOPLAZİLİ HASTALARDA RUKSOLİTİNİB ETKİNLİK VE GÜVENLİĞİ: ÇOK MERKEZLİ VE GERİYE DÖNÜK ÇALIŞMA.

SOYER N., TURGUT M., HAZNEDAROĞLU İ. C., YILMAZ A. F., AYDOĞDU İ., PİR A., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 1 - 04 Kasım 2017, (Özet Bildiri)

37. The Effects of Obesity and Age on Total Antioxidant/Oxidant Status in Healty Adsults

yıldız ş. m., derya k., ÇOĞUN H. Y., guvenç B.
international Congress of Health and Environment, 23 - 25 Ekim 2017, ss.285, (Özet Bildiri) Sürdürülebilir Kalkınma

38. ASSESSMENT OF THE MTHFR C677T AND APOB G10708A GENE POLYMORPHISMS RELATED TO CARDIOVASCULAR DISEASES IN HEALTHY BLOOD DONORS

KOCAMAZ D., Menziletoğlu Yıldız Ş., Güvenç B.
Uluslararası Sağlık ve Çevre Kongresi, Adana, Türkiye, 23 - 25 Ekim 2017, ss.142, (Özet Bildiri) Sürdürülebilir Kalkınma

39. SUCCESSFUL PREGNANCY AND DELIVERY IN AFIBRINOGENEMIA PATIENT: CASE REPORT

DİNÇYÜREK H. D., Mutlu Y. G., Cor S., Gok G., Evruke C., Demir C., et al.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri) identifier

40. HODGKIN LYMPHOMA TRANSFORMATION OF CHRONIC LYMPHOCYTIC LEUKEMIA: A CASE REPORT

DİNÇYÜREK H. D., MUTLU Y. G., KIS C., GÜVENÇ B.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri) identifier

41. EFFECTIVE RITUXIMAB THERAPY OF PLASMA EXCHANGE AND STREOID RESISTANT SEVERE AUTOIMMUNE HEMOLYTIC ANEMIA DUE TO ANTIPHOSPHOLIPID SYNDROME: CASE REPORT

KIS C., DİNÇYÜREK H. D., MUTLU Y. G., GÜVENÇ B.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri) identifier

42. TREATMENT OF REFRACTORY LANGERHANS CELL HISTIOCYTOSIS WITH CLADRIBINE: CASE REPORT

Kis C., DİNÇYÜREK H. D., Mutlu Y. G., GÜVENÇ B.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri) identifier

43. BORTEZOMIB THERAPY IN A REFRACTORY IMMUN HEMOLYTIC ANEMIA AS A STEROID SPARING AGENT

DİNÇYÜREK H. D., Mutlu Y. G., Kis C., GÜVENÇ B.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri) identifier

44. BORTEZOMIB AND RITUXIMAB COMBINATION AS A SALVAGE THERAPY IN A PATIENT WITH REFRACTORY THROMBOTIC THROMBOCYTOPENIC PURPURA: CASE REPORT

Mutlu Y. G., DİNÇYÜREK H. D., Kis C., GÜVENÇ B.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri) identifier

45. HISTORY OF CML

GÜVENÇ B.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri) identifier

46. PROTHROMBIN COMPLEX CONCENTRATE (PCC) PROPHYLAXIS IN PATIENT WITH HEREDITARY COMBINED VITAMIN K-DEPENDENT CLOTTING FACTORS DEFICIENCY (VKCFD): CASE REPORT

Kis C., DİNÇYÜREK H. D., Mutlu Y. G., Cor S., GÜVENÇ B.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri) identifier

47. Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis

SOYER N., TURGUT M., HAZNEDAROĞLU İ. C., yılmaz f., AYDOĞDU İ., PİR A., et al.
AHOS, 21 - 24 Eylül 2017, (Özet Bildiri)

48. Assessment of the prevelance of factor II and factor V Leiden gene polymorphisims related to cardiovascular diseases in healthy blood donors

KOCAMAZ D., Güvenç B., Menziletoğlu Yıldız Ş.
42nd FEBS Congress, Kudüs, İsrail, 10 - 14 Eylül 2017, ss.1, (Özet Bildiri) Sürdürülebilir Kalkınma

49. Assessment of the prevalence of factor II and factor V Leiden gene polymorphisms related to cardiovascular diseases in healthy blood donors

MENZİLETOĞLU YILDIZ Ş. S., Saygılı Yılmaz E., KOCAMAZ D., NYIRAHABIMANA F., SÖNMEZ E., GÜVENÇ B.
42nd FEBS Congress, From Molecules to Cells and Back, İsrail, 10 - 14 Eylül 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

50. Efficiacy and safety of ruxolitinib in Turkish patients with chronic myeloprolipherative neoplasms:A multicenter and retropective analysis

SOYER N., TURGUT M., HAZNEDAROĞLU İ. C., YILMAZ F., AYDOĞDU İ., PİR A., et al.
4th Aegean Hematology Oncology Symposium, 21 - 24 Eylül 2017, (Tam Metin Bildiri)

51. Assesment of the prevalence of factor II and factor V Leiden gene polymorphisms related to cardiovascular diseases in healthy blood donors

Yildiz S. S. M., Yilmaz E. S., Kocamaz D., Nyirahabimana F., Sonmez E., Guvenc B.
42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back, Jerusalem, İsrail, 10 - 14 Eylül 2017, cilt.284, ss.120, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

52. GENE EXPRESSION OF MICA AND MICB IN SEPSIS PATIENTS

Yildiz Ş. S., Atli G., Guvenc B., Ozcengiz D.
7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri) identifier

53. Gene expression of MICA and MICB in sepsis patient

YILDIZ S. M., ATLI G., GULEC E., GUVENC B., Ozcengiz D.
41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.79-80, (Özet Bildiri) identifier

54. DETERMINATION OF REFERENCE INTERVALS FOR HEMOGLOBIN OF ADANA POPULATION

MENZİLETOĞLU YILDIZ Ş. S., GÜVENÇ B.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2015, cilt.38, ss.28, (Tam Metin Bildiri) Creative Commons License

55. SCREENING TEST SEROPREVALENCE OF BLOOD DONORS: THE RESULTS OF BALCALI HOSPITAL BLOOD CENTER, UNIVERSITY OF CUKUROVA

GÜVENÇ B., menziletoğlu yıldız s. s.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, ss.38, (Tam Metin Bildiri)

56. University of Çukurova Balcalı Hospital Regional Blood Center Clinical Satisfaction Analysis

MENZİLETOĞLU YILDIZ Ş. S., GÜVENÇ B.
VI.International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, ss.25, (Tam Metin Bildiri) Creative Commons License

57. AN OLD FRIEND BECOMES THE ENEMY: ARTEFACTUALLY LOW HBA1C CASE

Bulut Y., Taktakoglu O., Sumbul H., Erdogan M., Elmas D., Guvenc B.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri) identifier

58. A SINISTER ENEMY IN THE WORLD OF THYROID BEXAROTENE (TARGRETIN)

Taktakoglu O., Tohumcuoglu M., Aydinalp Y., Sumbul H., Bozkurt A., Guvenc B.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri) identifier

59. UNIVERSITY OF CUKUROVA BALCALI HOSPITAL REGIONAL BLOOD CENTER CLINICAL SATISFACTION ANALYSIS

YILDIZ S., KARABOGA G., DENGIZ H., BUCAK Z., KOCAMAZ D., GUNEY E., et al.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri) identifier

60. CIRCUMCISION AND COMPLICATIONS IN ADOLESCENT AND ADULT PATIENTS WIITH HEMOPHILIA IN SOUTHERN PART OF TURKEY

Sasmaz I., Antmen B., Guvenc B., Karagun B., Kilinc Y., Aridogan A.
20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.669, (Özet Bildiri) identifier

61. NILOTINIB RESULTS IN IMPROVED RATES OF MOLECULAR RESPONSE IN TURKISH NEWLY DIAGNOSED CML-CP PATIENTS: A 24-MONTH UPDATE

Saydam G., Haznedaroglu I. C., Kaynar L., Yavuz A. S., Ali R., Guvenc B., et al.
20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.695-696, (Özet Bildiri) identifier

62. Çocuk yoğun bakımda plazmaferez uygulamaları ve ilişkili komplikasyonlar Çukurova Üniversitesi deneyimi

Tekinturhan F., YILDIZDAŞ R. D., ÖZGÜR HOROZ Ö., Karagün B., ERBEY M. F., ÜNAL İ., et al.
Uluslararası Katılımlı VII. Ulusal Çocuk Acil Tıp ve Yoğun Bakım Kongresi, Türkiye, 22 Mart 2010 - 26 Nisan 2015

63. DETERMINATION OF REFERENCE INTERVALS FOR HEMOGLOBIN OF ADANA POPULATION

Yildiz Ş. S., Karaboga G., Bayar A. K., Irencin F., Kaya A. N., Dagoglu B., et al.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2014, cilt.38, (Özet Bildiri) identifier identifier

64. SCREENING TEST SEROPREVALENCE OF BLOOD DONORS: THE RESULTS OF BALCALI HOSPITAL BLOOD CENTER, UNIVERSITY OF CUKUROVA

Karaboga G., Yildiz Ş. S., Bilgic T., Bayar A. K., Guvenc B.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2014, cilt.38, (Özet Bildiri) identifier identifier

65. Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia

Saydam G., Haznedaroglu I. C., Kaynar L., Yavuz A. S., Ali R., Guvenc B., et al.
cilt.122, (Özet Bildiri) identifier

66. The treatment effectiveness of therapeutic erythrocyte apheresis in carbonmonoxide poisoning

TÜRKMEN H. C., GÖKEL Y., DİŞEL N. R., TEKİN TURHAN F., GÜVENÇ B.
7th Mediterranean Emergency Medicine Congress, Marsilya, Fransa, 8 - 11 Eylül 2013

67. Patient with Sickle Cell A A Case of Acute Liver Failure in a Patient with Sickle Cell Anemia and G6PD Deficiency Treated with Plasmapheresis Successnemia and G6PD Deficiency Treated with Plasmapheresis Successfully

CANDEVİR ULU A., KURAN S., KURTARAN B., İNAL A. S., KÖMÜR S., TEKİNTURHAN F., et al.
APASL 2013, Singapore, Singapur, 6 - 10 Haziran 2013

68. Patient with Sickle Cell Anemia and G6PD Deficiency Treated with Plasmapheresis Successnemia and G6PD Deficiency Treated with Plasmapheresis Successfully

ULU A., KURAN S., KURTARAN B., İNAL A. S., KÖMÜR S., TEKİNTURHAN F., et al.
APASL 2013, Singapur, 6 - 10 Haziran 2013

69. Karbonmonoksit zehirlenmesinde iyileştirici eritrosit aferezinin tedavide etkinliği

TÜRKMEN H. C., GÖKEL Y., DİŞEL N. R., TURHAN F. T., GÜVENÇ B.
IX. Ulusal Acil Tıp Kongresi, Antalya, Türkiye, 23 - 26 Mayıs 2013

70. Comparison of Cobe Spectra and Spectra Optia Cell Separators for Red Blood Cell Exchange in Sickle Cell Disease

TEKİN TURHAN F., KARAGÜN B. Ş., ACIPAYAM C., ANTMEN A. B., TANYELİ A., GÜVENÇ B.
34th Annual Meeting of the American Society for Apheresis, Amerika Birleşik Devletleri, 22 Mayıs 2013, cilt.28, ss.89-90, (Tam Metin Bildiri)

71. Leukocyte Depletion for a Newborn Weighing 2900 Grams

Tekin Turhan F., MERT M. K., YAPICIOĞLU YILDIZDAŞ H., YILDIZDAŞ R. D., ÖZLÜ F., GÜVENÇ B.
34th Annual Meeting of the American Society for Apheresis, Denver, Amerika Birleşik Devletleri, 22 Mayıs 2013, cilt.28, ss.138, (Tam Metin Bildiri)

72. Granülosit Aferezi ile Elde Edilen Ürünlerde Kalite Kontrol Sonuçları Çukurova Üniversitesi Deneyimi

Önal A., Tekin Turhan F., Karadamar M., Ergül Ş., Boyraz D., Yanık S., et al.
IV. Ulusal Kan Merkezleri ve Transfüzyon Tıbbi Kongresi, Antalya, Türkiye, 4 - 07 Eylül 2012

73. Granulocyte transfusion in paediatric oncology patients with febrile neutropenia

SEZGİN G., ACIPAYAM C., ÖZKAN A. K., YILMAZ Ş., TEKINTURHAN F., BAYRAM İ., et al.
38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), Geneva, İsviçre, 1 - 04 Nisan 2012, cilt.47, (Özet Bildiri) identifier

74. Hemşirelerde Kan Ürünleri ve Transfüzyon Uygulamaları Anketi Çukurova Üniversitesi Balcalı Hastanesi Sonuçları

Karaboğa G., Tekin Turhan F., Ak N., Kurtboğanoğlu G., Candevir A., SERTDEMİR Y., et al.
13. Ulusal Hemşirelik Kongresi, Şanlıurfa, Türkiye, 19 - 21 Ekim 2011

75. Trombosit aferezi bağışçılarında ret nedenleri ve oranları 2009 2010 yıllarının karşılaştırılması

Kartal G., TEKİN TURAN F., Poçulu Ş., AZGIN H., AKKAN Ö., ERGÜL Ş., et al.
III. Ulusal Kan Merkezleri ve Transfüzyon Tıbbi Kongresi, Antalya, Türkiye, 24 - 28 Kasım 2010

76. COBE Spectra ile yapılan granülosit aferezi işlemlerinde verimi etkileyen faktörler

Karaboğa G., Tekin Turhan F., Ak N., Kurtboğanoğlu G., Candevir A., SERTDEMİR Y., et al.
III. Ulusal Kan Merkezleri ve Transfüzyon Tıbbi Kongresi, Antalya, Türkiye, 24 - 28 Kasım 2010

77. Granülosit Aferezi işlemlerinin Donörlerin Kan tablosunda neden olduğu değişim ve komplikasyonların analizi

Karaboğa G., Tekin Turhan F., Ak N., Kurtboğanoğlu G., Candevir A., SERTDEMİR Y., et al.
III. Ulusal Kan Merkezleri ve Transfüzyon Tıbbi Kongresi, Antalya, Türkiye, 24 - 28 Kasım 2010

78. Tam kan donasyonlarında dönör reaksiyonları Çukurova Üniversitesi deneyimi

Kartal G., TEKİN TURAN F., Poçulu Ş., AZGIN H., AKKAN Ö., ERGÜL Ş., et al.
III. Ulusal Kan Merkezleri ve Transfüzyon Tıbbi Kongresi, Antalya, Türkiye, 24 - 28 Kasım 2010

79. Çukurova Üniversitesi Kan merkezi ne başvuran donörlerin kan grubu dağılımı

Karaboğa G., Tekin Turhan F., Ak N., Kurtboğanoğlu G., Candevir A., SERTDEMİR Y., et al.
I. Uluslararası Avrasya Hematoloji Kongresi, Antalya, Türkiye, 7 - 10 Kasım 2010 Sürdürülebilir Kalkınma

80. Terapötik aferez uygulamalarında damar yolu seçimi ve ilişkili komplikasyonlar 3500 işlemin retrospektif analizi

Karaboğa G., Tekin Turhan F., Ak N., Kurtboğanoğlu G., Candevir A., SERTDEMİR Y., et al.
I. Uluslararası Avrasya Hematoloji Kongresi, Antalya, Türkiye, 7 - 10 Kasım 2010

81. Çocuk Yoğun bakım ünitelerinde trombositopeni ve koagülopati mortaliteyi etkiliyor mu?

ÖZGÜR HOROZ Ö., Tekinturhan F., Türhüt S., Karadamar M., YILDIZDAŞ R. D., Güvenç B.
VII. Ulusal çocuk acil tıp ve yoğun bakım kongresi, Adana, Türkiye, 01 Ocak 2010, (Tam Metin Bildiri)

82. Characterization of hematopoietic and non-hematopoietic stem/progenitor cells in freshly isolated adult human bone marrow using an 8-color flow cytometric assay

Tekinturhan F., Zimmerlin L., Donnenberg V. S., Pfeifer M. E., Monlish D. A., GÜVENÇ B., et al.
49th Annual Meeting of the American-Society-of-Hematology, Georgia, Amerika Birleşik Devletleri, 8 - 11 Aralık 2007, cilt.110, (Özet Bildiri) identifier

83. Lipid Aferezi Çukurova Üniversitesi Tıp Fakültesi Terapötik Aferez Ünitesi Deneyimi

KÜSTÜ A., ÇINAR H., TÜRGÜT S., ÇELEBİ K., TULUN G., İNCE G., et al.
XXXIII. Ulusal Hematoloji Kongresi, Türkiye, 16 - 19 Ekim 2007

84. Succesfull Treatment of Hepatic Failure Due to Acetaminophen Poisoning with FPSA

SEBE A., SATAR S., DİŞEL N. R., MURT M., GÖKEL Y., GÜVENÇ B.
The Fourth Mediterrenian Emergency Medicine Congress, Sorrento, İtalya, 15 - 19 Eylül 2007

85. TTP Gibi Seyreden SLE Olgusu

GÜVENÇ B., GÜRKAN E., ÜNSAL Ç., SARITAŞ B., TAŞ A., EVRAN M., et al.
30. Ulusal Hematoloji Kongresi, Türkiye, 10 - 14 Ekim 2003

86. Soğuk Aglutinin Hastalığı

GÜVENÇ B., GÜRKAN E., ÜNSAL Ç., SARITAŞ B., TAŞ A., EVRAN M., et al.
30. Ulusal Hematoloji Kongresi, Türkiye, 10 - 14 Ekim 2003

87. Extramedüller hematopoesisle seyreden PRV olgusu

GÜVENÇ B., GÜRKAN E., ÜNSAL Ç., TAŞ A., SARITAŞ B., EVRAN M., et al.
30.Ulusal Hematoloji Kongresi, Türkiye, 10 - 14 Ekim 2003

88. Electron Microscopic Examination of Kidney Tissue of Streptozotocin (STZ) Induced Diabetic Rats.

TAMER L., POLAT S., KARAYAYLALI İ., GÜVENÇ B., METE U. Ö., İspir T., et al.
XXXIIIrd Congress of the European Renal Association European Dialysis and Transplant Association, Amsterdam, Hollanda, 18 - 21 Haziran 1996, ss.26, (Özet Bildiri) Sürdürülebilir Kalkınma
Metrikler

Yayın

154

Yayın (WoS)

87

Yayın (Scopus)

49

Atıf (WoS)

241

H-İndeks (WoS)

9

Atıf (Scopus)

405

H-İndeks (Scopus)

12

Atıf (Scholar)

863

H-İndeks (Scholar)

17

Proje

12

Açık Erişim

12
BM Sürdürülebilir Kalkınma Amaçları